Meridian Bioscience, Inc. (VIVO) Reports Second Quarter 2014 Operating Results And Revises Fiscal 2014 Guidance
4/24/2014 7:26:27 AM
Meridian Bioscience, Inc. (NASDAQ: VIVO):
Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
•reported record fiscal 2014 second quarter and first six months net sales of $50.1 million and $94.9 million, respectively, increases of 6% and 2%, respectively, from the same periods of the prior fiscal year
Help employers find you! Check out all the jobs and post your resume.
comments powered by